1. Introduction
===============

*Skimmia laureola* (DC.) Decne (Rutaceae) is an aromatic shrub distributed from northern China to the Northern Himalayas; its leaves give off an aromatic smell when crushed. Traditionally, the plant is used in folk and cultural practices: the smoke of dried leaves is considered useful to ward off evils \[[@B1-molecules-20-04735]\] and leaves are arranged in garlands and considered sacred \[[@B2-molecules-20-04735]\]. In traditional medicine the leaves are employed as an antitussive and, when dried and crushed, as a veterinary anthelmintic, and as an insecticide and pesticide. The smoke of the dried leaves is used to clear the nasal tract and for cold, fever and headache treatment \[[@B3-molecules-20-04735]\]. Previous phytochemical studies reported the composition of the essential oil from *Skimmia laureola* from different areas \[[@B4-molecules-20-04735],[@B5-molecules-20-04735],[@B6-molecules-20-04735],[@B7-molecules-20-04735],[@B8-molecules-20-04735]\]. Triterpenoids \[[@B9-molecules-20-04735],[@B10-molecules-20-04735]\], alkaloids and coumarins have also been reported \[[@B11-molecules-20-04735]\] in the plant. The essential oil has been evaluated for its antimicrobial and insect-repellent activities \[[@B4-molecules-20-04735],[@B7-molecules-20-04735],[@B12-molecules-20-04735]\], and for acute toxicity, antinociceptive, antipyretic and anticonvulsant properties \[[@B13-molecules-20-04735]\]. Quinoline alkaloids isolated from *S. laureola* have shown cholinesterase inhibiting and calcium blocking properties \[[@B10-molecules-20-04735]\] and tyrosinase inhibiting activity \[[@B14-molecules-20-04735]\]. Extracts of the plant have demonstrated antipyretic and antinociceptive \[[@B15-molecules-20-04735]\], antifungal \[[@B16-molecules-20-04735]\] and mutagenic activities \[[@B17-molecules-20-04735]\]. There is limited research on its essential oil as a flavor or fragrance, so in this paper we report the composition of the essential oil from the leaves of *Skimmia laureola* collected in Pakistan and its possible antispasmodic, antibacterial, antifungal, phytotoxic and cytotoxic effects.

2. Results and Discussion
=========================

[Table 1](#molecules-20-04735-t001){ref-type="table"} reports the composition of essential oil from leaves of *Skimmia laureola*. On a fresh weight basis, the yield of the essential oil was 0.7%. Twenty-eight components were identified, accounting for 93.9% of the total oil. The oil is mainly composed by monoterpenes (93.5%), of which oxygenated monoterpenes represent 82.5% of the total oil. Sesquiterpenes constitute only 0.3% of the total oil. Linalyl acetate is the main component (50.5%), with linalool (13.1%), geranyl acetate (8.5%) and *cis*-*p*-menth-2-en-1-ol (6.2%) as principal constituents. This composition agrees with previously published data \[[@B5-molecules-20-04735],[@B6-molecules-20-04735],[@B7-molecules-20-04735],[@B8-molecules-20-04735]\] and seems to also be characteristic of other *Skimmia* essential oils, such as S*kimmia anquetilia* N. P. Taylor & Airy Shaw \[[@B18-molecules-20-04735]\].

molecules-20-04735-t001_Table 1

###### 

Composition of the essential oil from leaves of *Skimmia laureola.*

                                   Ki ^a^   Ki ^b^   \%         Identification ^c^
  -------------------------------- -------- -------- ---------- --------------------
  (−)-Camphene                     953      1076     T ^d^      1, 2, 3
  Δ3-Carene                        1008     1173     T          1, 2, 3
  Caryophyllene oxide              1581     2008     T          1, 2, 3
  Geranyl acetate                  1379     1765     8.5        1, 2
  *cis*-*p*-Menth-2-en-1-ol        1128     1638     6.2        1, 2
  Linalyl acetate                  1253     1665     50.5       1, 2
  β-Myrcene                        986      1162     3.4        1, 2, 3
  (*Z*)-β-Ocimene                  1034     1243     2.3        1, 2
  α-Pinene                         921      1032     2.2        1, 2, 3
  Linalool                         1096     1553     13.1       1, 2, 3
  Neryl acetate                    1367     2097     1.7        1, 2
  (*E*)-β-Ocimene                  1044     1262     1.6        1, 2
  Sabinene                         966      1132     1.0        1, 2
  *p*-Menth-1-en-8-ol, acetate     1346     1738     1.0        1, 2
  Geraniol                         1255     1857     0.9        1, 2
  β-Phellandrene                   1029     1218     0.3        1, 2, 3
  β-Pinene                         978      1118     0.1        1, 2, 3
  1,8-Cineole                      1024     1213     0.1        1, 2, 3
  Terpinolene                      1083     1265     0.1        1, 2
  Terpinen-4-ol                    1173     1611     0.1        1, 2, 3
  Octyl acetate                    1208     1436     0.1        1, 2
  Citral                           1270     1727     0.1        1, 2
  Bornyl acetate                   1284     1591     0.1        1, 2
  *cis*-Limonene oxide             1132     1450     0.1        1, 2
  Caryophyllene                    1408     1666     0.1        1, 2
  α-Limonene diepoxide             1345              0.1        1, 2
  γ-Elemene                        1436     1650     0.1        1, 2
  *trans*-Nerolidol                1565     2050     0.1        1, 2
  **Total**                                          **93.9**   
  **Monoterpene Hydrocarbons**                       **11.0**   
  **Oxygenated Monoterpenes**                        **82.5**   
  **Sesquiterpene Hydrocarbons**                     **0.2**    
  **Oxygenated Sesquiterpenes**                      **0.1**    
  **Other compounds**                                **0.1**    

Notes: ^a^: Kovats retention index determined relative to the t~R~ of a series of *n*-alkanes (C~10~--C~35~) on HP-5 MS column. ^b^: Kovats retention index determined relative to the t~R~ of a series of *n*-alkanes (C~10~--C~35~) on HP Innowax. ^c^: 1 = Kovats retention index, 2 = mass spectrum, 3 = co-injection with authentic compound. ^d^: T = trace ( \<0.1%).

[Table 2](#molecules-20-04735-t002){ref-type="table"} reports the antibacterial activity of three different doses of *S. laureola* essential oil. It was found active against five of the tested bacterial strains. *M. luteus* and *S. viridans* were found to be more susceptible, whereas no activity was found against *P. aeruginosa* and *B. subtilis*.
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###### 

Antibacterial effects of the essential oil of the leaves of *Skimmia laureola* (SVO).

  Microorganism     SVO 125 µg/mL   SVO 250 µg/mL   SVO 500 µg/mL   DMSO    Imipenem
  ----------------- --------------- --------------- --------------- ------- -----------
  *M. luteus*       20.0 ± 1.33     21.2 ± 1.21     23.5 ± 1.87     \-\--   28 ± 0.23
  *E. coli*         11.0 ± 1.58     10.2 ± 0.87     11.3 ± 1.67     \-\--   30 ± 0.10
  *S. aureus*       13.0 ± 1.88     13.8 ± 0.95     14.0 ± 1.40     \-\--   24 ± 0.65
  *P. multocida*    15.8 ± 1.41     15.6 ± 1.98     16.3 ± 1.76     \-\--   32 ± 0.24
  *P. aeruginosa*   \-\--           \-\--           \-\--           \-\--   \-\--
  *B. subtilis*     \-\--           \-\--           \-\--           \-\--   \-\--
  *S. viridans*     15.3 ± 0.92     16.2 ± 2.23     18.5 ± 1.45     \-\--   22 ± 0.45

Data are the mean ± SEM of three replicates.

The presence of high percentages of linalyl acetate and linalool in the oil can explain this activity. In fact, these compounds have been reported for their antibacterial properties, due to their ability to cross cell membranes, penetrating into the interior of the cell and interacting with critical intracellular sites \[[@B19-molecules-20-04735]\].

The essential oil was evaluated for its antifungal activity ([Table 3](#molecules-20-04735-t003){ref-type="table"}). All the tested fungal strains were inhibited in a concentration-dependent manner. The maximum inhibitory effect was observed for *C. albicans*, *A. flavus* and *T. longifusis*, at a dose of 125 µg/mL. Essential oils have been reported as antifungal agents and monoterpene-rich essential oils were active, particularly against *Candida* species \[[@B20-molecules-20-04735]\]. Moreover, linalool is reported as an antifungal agent against several strains \[[@B21-molecules-20-04735]\] and linalyl acetate has been reported for its activity against several *Candida* species \[[@B22-molecules-20-04735]\].
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###### 

Antifungal effect of the essential oil of the leaves of *Skimmia laureola* (SVO).

                    Percent Inhibition of Mycelia Growth                                      
  ----------------- -------------------------------------- -------------- -------------- ---- --------------
  *T. longifusis*   62.66 ± 1.34                           63.45 ± 1.45   67.65 ± 1.40   \-   70.98 ± 0.40
  *C. albicans*     67.32 ± 0.90                           77.0 ± 1.56    83.87 ± 1.98   \-   89.87 ± 0.22
  *F. solani*       45.64 ± 1.40                           56.7 ± 1.21    62.96 ± 1.11   \-   73.98 ± 1.87
  *M. canis*        30.37 ± 1.97                           32.33 ± 1.17   50.00 ± 1.60   \-   94.87 ± 0.99
  *A. flavus*       64.45 ± 1.98                           67.77 ± 1.88   70.97 ± 1.66   \-   20.56 ± 0.65
  *C. glabrata*     28.00 ± 1.14                           61.33 ± 1.40   82.35 ± 1.49   \-   93.98 ± 0.76

Data are the mean ± SEM of three replicates.

The essential oil was found to be phytotoxic in the *Lemna minor* test, with an LD~50~ of 46.09 μg/mL ([Table 4](#molecules-20-04735-t004){ref-type="table"}). A significant dose-dependent cytoxicity was observed for all the doses tested ([Table 5](#molecules-20-04735-t005){ref-type="table"}). The essential oil showed outstanding cytotoxic activity with an LD~50~ value of 11.01 µg/mL. Significant brine shrimp mortality was found at 10 µg/mL. Essential oils and monoterpenoids are well known as phytotoxic agents \[[@B23-molecules-20-04735],[@B24-molecules-20-04735]\]. Linalool and linalyl acetate showed moderate inhibitory effects against *Raphanus sativus* L. and *Lepidium sativum* L. germination, but considerable inhibition against radical elongation of these test species \[[@B25-molecules-20-04735]\].
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###### 

Phytotoxic effects of the essential oil of the leaves of *Skimmia laureola*.

  Essential Oil   Number of Fronds   Living Fronds   Dead Fronds
  --------------- ------------------ --------------- -------------
  10 µg/mL        52                 30 ± 0.22       22 ± 1.89
  100 µg/mL       52                 21 ± 1.11       31± 1.99
  1000 µg/mL      52                 22 ± 1.00       30 ± 1.40

Data are the mean ±SEM of three replicates.
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###### 

Cytotoxic effects of the essential oil of the leaves of *Skimmia laureola*.

  Essential Oil   Number of Brine Shrimps   Living Brine Shrimps   Dead Brine Shrimps
  --------------- ------------------------- ---------------------- --------------------
  10 µg/mL        30                        8 ± 1.34               22 ± 1.98
  100 µg/mL       30                        3 ± 1.00               27 ± 1.56
  1000 µg/mL      30                        0.9 ± 1.98             29.1 ± 1.75

Data are the mean ± SEM of three replicates.

Some essential oil have been reported for their toxicity in brine shrimp test \[[@B26-molecules-20-04735]\]. It is of importance that data obtained by this test in most cases correlates reasonably well with cytotoxicity and anti-tumor properties \[[@B27-molecules-20-04735]\].

It is evident from [Figure 1](#molecules-20-04735-f001){ref-type="fig"} and [Figure 2](#molecules-20-04735-f002){ref-type="fig"} that the essential oil of *S. laureola* significantly relaxed the contracted smooth muscles, in a dose-dependent manner. The spasmolytic effect of the oil started at 0.03 mg/mL and was 100% at a dose of 10 mg/mL.

![Dose response curve of *Skimmia laureola* essential oil (SVO) on isolated rabbit's jejunum preparations. All values are the mean ± SEM, n = 5.](molecules-20-04735-g001){#molecules-20-04735-f001}

![Effect of *Skimmia laureola* essential oil (mg/mL) on isolated rabbit jejuum.](molecules-20-04735-g002){#molecules-20-04735-f002}

The essential oil showed a remarkable antispasmodic activity, in spontaneous and KCl-induced contraction in isolated rabbit jejunum. The contraction of smooth muscle of rabbit jejunum is due to an increased concentration of free calcium in the cytoplasm, which stimulates the chemical mediators responsible for the contraction. This increase in calcium level may be either due to influx via voltage-dependent calcium channels or a direct release of calcium from the endoplasmic reticulum. Thus, a periodic depolarization is created due to high speed action potential. When there is an increase of potassium concentration, the contraction of the smooth muscle will increase due to rapid action potential. When the calcium channel is blocked through a calcium channel blocker agent, the contracted smooth muscle will relax. The muscle relaxation caused by *S. laureola* essential oil suggests that its possible mode of action is either by blocking the release of stored calcium from the sarcoplamic reticulum or by blocking the calcium channels.

3. Experimental Section
=======================

3.1. Plant Collection
---------------------

*Skimmia laureola* was collected in Patrak (Upper Dir), Pakistan, and shortly quickly at 4 °C in the dark. The plant was identified by Dr. Barkatullah and a voucher specimen (Bot. 8815) is kept in the herbarium of the Department of Botany, University of Peshawar, Pakistan.

3.2. Isolation of Volatile Oil
------------------------------

One hundred g of dried leaves of *S. laureola* were ground in a Waring blender and then subjected to hydrodistillation for 3 h, according to the standard procedure described in the *European Pharmacopoeia* \[[@B28-molecules-20-04735]\]. The oil was solubilized in *n*-hexane, filtered over anhydrous sodium sulfate and stored under N~2~ at +4 °C in the dark until tested and analyzed.

3.3. GC-FID and GC/MS Analyses and Identification of Essential Oil Components
-----------------------------------------------------------------------------

Analytical gas chromatography was carried out on a Perkin-Elmer Sigma-115 gas chromatograph equipped with a FID and a data handling processor. The separation was achieved using a HP-5MS fused-silica capillary column (30 m × 0.25 mm i.d., 0.25 μm film thickness). Column temperature: 40 °C, with 5 min initial hold, and then to 270 °C at 2 °C/min, 270 °C (20 min); injection mode splitless (1 μL of a 1:1000 *n*-hexane solution). Injector and detector temperatures were 250 and 290 °C, respectively. Analysis was also run by using a fused silica HP Innowax polyethylene glycol capillary column (50 m × 0.20 mm i.d., 0.25 μm film thickness). In both cases, helium was used as carrier gas (1.0 mL/min). GC/MS analysis was performed on an Agilent 6850 Ser. II apparatus, fitted with a fused silica DB-5 capillary column (30 m × 0.25 mm i.d., 0.33 μm film thickness), coupled to an Agilent Mass Selective Detector MSD 5973; ionization energy voltage 70 eV; electron multiplier voltage energy 2000 V. Mass spectra were scanned in the 40--500 amu range, scan time was 5 scans/s. Gas chromatographic conditions were as reported above; transfer line temperature, 295 °C. Most constituents were identified by gas chromatography by comparison of their Kovats retention indices (Ri) \[determined relative to the *t*R of *n-*alkanes (C~10~--C~35~)\], with either those of the literature \[[@B29-molecules-20-04735]\] or by comparison of mass spectra on both columns with those of authentic compounds available in our laboratories by means of the NIST 02 and Wiley 275 libraries \[[@B30-molecules-20-04735],[@B31-molecules-20-04735],[@B32-molecules-20-04735],[@B33-molecules-20-04735]\]. The component relative concentrations were obtained by peak area normalization. No response factors were calculated.

3.4. Antibacterial Activity
---------------------------

Antibacterial activity was measured by the agar well diffusion method, against four Gram (+) \[*Micrococcus luteus* ATCC 9341, *Staphylococcous aureus* ATCC 25923, *Bacillus subtilis* ATCC 6633, *Streptococcus viridians* ATCC 10556\] and three Gram (−) \[*Escherichia coli* ATCC25922, *Pasteurella multocida* (clinical isolate), *Psuedomonas aeruginosa* ATCC 27853\] strains, purchased from Schazo Laboratories (Lahore, Pakistan) and Schering Pharmaceutical Industries Ltd.Lahore, Pakistan). Bacterial strains were first cultured on nutrient broth and incubated for 24 h. Nutrient agar was melted, cooled to 40 °C and poured into sterilized Petri dishes. Four-height hold bacterial culture was spread on the surface of nutrient agar. The experiment was repeated thrice turning the plate 60° between each streaking. About l00 µL of 3 mg/mL of essential oil dissolved in DMSO was then added to the wells. Other wells were supplemented with DMSO and 10 µg imipenem, used as positive and negative control, respectively. The plates were then incubated for 24 h at 37 °C. The plates were then observed for zones of inhibition, measuring the inhibition zones by using a caliper, mm/inch reading scale, precision 0.05 mm. All the experiments were conducted in triplicate.

3.5. Anti-Fungal Activity
-------------------------

The antifungal activity was assayed against six fungal strains: *Tricophyton longifusis* (clinical isolate), *Candida albicans* (ATCC 2091), *Fusarium solani* (ATCC 11712), *Microsporum canis* (ATCC 111622), *Aspergillus flavus* (ATCC 32611), and *Candida glabrata* (ATCC 90030). Twenty four mg of essential oil was dissolved in 1 ml sterile DMSO serving as a stock solution. Four mL of Sabouraud dextrose agar (SDA) growth media was transferred to each screw capped tube, under sterile conditions and autoclaved at 121 °C for 15 min. These tubes were then allowed to cool to 50 °C and 400 µg/mL test sample were added to the SDA tubes, which were then allowed to solidify at room temperature. DMSO and miconazole were used as negative and positive controls, respectively. The tubes were incubated at 28 ± 1 °C for 7 days. Cultures were observed twice weekly during incubation. Growth in the media was estimated by measuring the linear growth (mm) by .using a caliper, mm/inch reading scale, precision 0.05 mm. The percentage inhibition of fungal growth was calculated as follows: where Gn = normal mycelial growth, Gt = mycelial growth in the test.

3.6. Phytotoxicity
------------------

The phytotoxic activity of the essential oil was evaluated using *Lemna minor* as test species, as previously reported \[[@B34-molecules-20-04735]\]. Fifteen mg of essential oil were dissolved in 15 mL of 2% DMSO and from this solution 5, 50 and 500 μL were transferred to flasks (three flasks for each concentration), to obtain solutions containing 10, 100 and 1,000 μg/mL, respectively. The solvent was allowed to evaporate overnight under sterilized condition in a laminar flow hood. Twenty mL of a medium of the following composition: KH~2~PO~4~ (680), KNO~3~ (1515), Ca(NO~3~)~2~·4H~2~O (1180), MgSo~4~·7H~2~O, H~3~BO~3~ (2.86), MnCl~2~·4H~2~O (3.62), FeCl~3~·4H~2~O (5.40), ZnSO~4~·5H~2~O (0.22), CuSO~4~·5H~2~O (0.22), Na~2~MoO~4~·2H~2~O (0.12), EDTA (11.20), were added to each flask. Other flasks (three for each test) were supplemented with the medium alone, to serve as a negative control. To each flask ten plants of *L. minor* with 2--3 fronds were transferred. The flasks were kept under about 12 h day light conditions. Plants were observed daily and on the seventh day the numbers of fronds were counted.

3.7. Cytotoxicity
-----------------

The cytotoxic activity of the essential oil of was tested using the brine shrimp assay as previously reported \[[@B34-molecules-20-04735]\]. About 20 mg of essential oil were dissolved in 2 mL 2% DMSO and from this solution 5, 50 and 500 μL were transferred to vials (three vials/concentration), to obtain final concentrations of 10, 100 and 1000 μg/mL, respectively. The solvent was allowed to evaporate overnight. Five mL of a seawater solution (38 g/L) were added to each vial. After 36 h of hatching and maturation of larvae as nauplii, 10 larvae were transferred to each vial using a Pasteur pipette. The vials were then placed at room temperature (25--27 °C) under illumination. Other vials were supplemented with brine solution and served as a negative control.

3.8. Animals
------------

Rabbits of either sex with (1.0--1.4 kg) were used. The animals were kept for 14 days before starting the experiments at the Animal House of the Department of Pharmacy, University of Malakand (Lower Dir, Pakistan), under standard conditions mentioned in the *Animals Bye-Laws 2008 of the University of Malakand (Scientific Procedures Issue-1)* and fed on standard diet and tap water. The animals were kept in fasting condition 24 h prior to the start of the experiments with free excess to water.

3.9. Antispasmodic Activity
---------------------------

Experiments on rabbit's jejunum preparations were carried as previously reported \[[@B35-molecules-20-04735]\]. Slaughtered animals were dissected to open the abdomen and jejunum portion(s) were extracted and kept in freshly prepared Tyrode's solution, aerated with Carbogen to keep them alive and ready for use. Quiescent sub-maximal doses of acetylcholine (0.3 μM) were used when needed for keeping the tissue viable and alive. A portion of about 1.5 cm length tissue was mounted in a 10 mL tissue bath containing Tyrode's solution and stabilized for 25--30 min. All the processes were carried out at 37 ±1 °C with constant aeration and kept under 1 *g* pressure. On attaining a reproducible response, test samples at the doses of 0.01, 0.03, 0.1, 0.3, 1.0, 3.0, 5.0, and 10.0 mg/mL essential oil were applied to the bath solution. The experiments were repeated thrice. For the determination of the possible mode of action, the tissue was pretreated with a high concentration KCl (80 mM) to cause depolarization and keep the tissue in sustained contraction. The essential oil was then applied in cumulative manner to obtain a dose dependent curve and relaxation. Intestinal responses data were recorded using a Force Transducer (MLT 0210/A, Pan Lab. S.I., Letica Scientific Instruments*,* Barcelona, Spain) attached with a Power lab (4/25 T, AD Instruments, Bella Vista, New South Wales, Australia). Data were recorded at a range of 20 mv.

3.10. Statistics and Interpretation
-----------------------------------

Chart 5 (AD Instruments) was used to interpret the graph tracings. Student *t* test was used at 95% confidence interval. *p* values less or equal to 0.05 were considered as statistically significant.

4. Conclusions
==============

The data obtained contribute to a phytochemical knowledge of the essential oil of an important flavor species, widely used in traditional medical practices. The chemical pattern of the essential oil agrees with the composition of other *Skimmia* essential oils. The oil showed antibacterial activity against some of the tested bacterial strains and such activity could be, at least in part, explained by the high percentage of linalyl acetate. On the other hand, the essential oil showed a good antifungal activity against some strains. Of interest seems the activity against *Candida albicans*, considering the pathogenicity of this microorganism. Data about the phytotoxicity of the essential oil agree with the available literature, that ascribes to the volatile fractions antigerminative and allelopathic properties. The muscle relaxation caused by *S. laureola* essential oil suggests that the possible mode of action is either by blocking the release of stored calcium from the sarcoplamic reticulum or by blocking the calcium channels. The data obtained can be useful in explaining the traditional uses of the plant.

*Sample Availability*: Samples of the essential oil are available from the authors.

B. and M.I provided the plant and extracted the essential oil; N.M. carried out the biological assays; V.D.F. studied the chemistry of the essential oil, provided important comments during the design of experiment and wrote the manuscript. All authors read and approved the final manuscript.

The authors declare no conflict of interest.
